RASGRF1 and neoplasm: Furthermore, we observed a significant reduction in the phosphorylation and expression levels of PDGFRB, RASGRF1, and BRAF proteins within the Focal Adhesion signaling pathway (Figure 5), which has been reported that elevated expression of these proteins promotes tumor progression and is strongly associated with poor prognosis in cancer patients (39, 40).